v3.22.2.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Net loss including noncontrolling interests $ (3,490,547) $ (6,605,145) $ (11,250,480) $ (11,891,791)
Other comprehensive loss:        
Foreign currency translation adjustment 69,949 0 43,862 0
Comprehensive loss including noncontrolling interests (3,420,598) (6,605,145) (11,206,618) (11,891,791)
Comprehensive loss attributable to noncontrolling interests (17,375) 0 (6,166) 0
Comprehensive loss attributable to Statera Biopharma, Inc. $ (3,437,973) $ (6,605,145) $ (11,212,784) $ (11,891,791)